Your browser doesn't support javascript.
loading
Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis.
Rahman, Proton; Ritchlin, Christopher T; Helliwell, Philip S; Boehncke, Wolf-Henning; Mease, Philip J; Gottlieb, Alice B; Kafka, Shelly; Kollmeier, Alexa P; Hsia, Elizabeth C; Xu, Xie L; Shawi, May; Sheng, Shihong; Agarwal, Prasheen; Zhou, Bei; Ramachandran, Paraneedharan; Zhuang, Yanli; McInnes, Iain B.
Afiliación
  • Rahman P; P. Rahman, MD, Memorial University of Newfoundland, St. John's, Newfoundland, Canada; prahman@mun.ca.
  • Ritchlin CT; C.T. Ritchlin, MD, MPH, University of Rochester, Rochester, New York, USA.
  • Helliwell PS; P.S. Helliwell, PhD, University of Leeds, Leeds, UK.
  • Boehncke WH; W.H. Boehncke, MD, Geneva University Hospitals, Geneva, Switzerland.
  • Mease PJ; P.J. Mease, MD, Swedish Medical Center/Providence St Joseph Health and University of Washington School of Medicine, Seattle, Washington, USA.
  • Gottlieb AB; A.B. Gottlieb, MD, PhD, Icahn Medical School at Mount Sinai, New York, New York, USA.
  • Kafka S; S. Kafka, MD, Janssen Scientific Affairs, Horsham, Pennsylvania, USA.
  • Kollmeier AP; A.P. Kollmeier, MD, X.L. Xu, PhD, Janssen Research & Development, San Diego, California, USA.
  • Hsia EC; E.C. Hsia, MD, Janssen Research & Development, Spring House, Pennsylvania, USA, and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
  • Xu XL; A.P. Kollmeier, MD, X.L. Xu, PhD, Janssen Research & Development, San Diego, California, USA.
  • Shawi M; M. Shawi, PhD, Immunology Global Medical Affairs, Janssen Pharmaceutical Companies of Johnson & Johnson, Horsham, Pennsylvania, USA.
  • Sheng S; S. Sheng, PhD, P. Agarwal, PhD, B. Zhou, PhD, P. Ramachandran, MD, MPH, Y. Zhuang, PhD, Janssen Research & Development, Spring House, Pennsylvania, USA.
  • Agarwal P; S. Sheng, PhD, P. Agarwal, PhD, B. Zhou, PhD, P. Ramachandran, MD, MPH, Y. Zhuang, PhD, Janssen Research & Development, Spring House, Pennsylvania, USA.
  • Zhou B; S. Sheng, PhD, P. Agarwal, PhD, B. Zhou, PhD, P. Ramachandran, MD, MPH, Y. Zhuang, PhD, Janssen Research & Development, Spring House, Pennsylvania, USA.
  • Ramachandran P; S. Sheng, PhD, P. Agarwal, PhD, B. Zhou, PhD, P. Ramachandran, MD, MPH, Y. Zhuang, PhD, Janssen Research & Development, Spring House, Pennsylvania, USA.
  • Zhuang Y; S. Sheng, PhD, P. Agarwal, PhD, B. Zhou, PhD, P. Ramachandran, MD, MPH, Y. Zhuang, PhD, Janssen Research & Development, Spring House, Pennsylvania, USA.
  • McInnes IB; I.B. McInnes, MD, PhD, University of Glasgow, Glasgow, UK.
J Rheumatol ; 48(12): 1815-1823, 2021 12.
Article en En | MEDLINE | ID: mdl-33934076
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Artritis Psoriásica Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Rheumatol Año: 2021 Tipo del documento: Article Pais de publicación: Canadá
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Artritis Psoriásica Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Rheumatol Año: 2021 Tipo del documento: Article Pais de publicación: Canadá